Kymera Therapeutics, Inc.
KYMR
$25.97
$0.953.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.37% | 53.70% | 38.73% | 31.16% | -7.93% |
| Total Receivables | -94.95% | -65.14% | -58.66% | -38.86% | 639.53% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 76.26% | 23.68% | 0.32% | 29.30% | 20.19% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 25.89% | 51.38% | 36.33% | 30.54% | -3.36% |
|
|
|||||
| Total Current Assets | 25.89% | 51.38% | 36.33% | 30.54% | -3.36% |
| Net Property, Plant & Equipment | -3.18% | 9.01% | 20.75% | 33.27% | 354.43% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.33% | -32.72% | -10.15% | -14.61% | -13.32% |
| Total Assets | 69.87% | 87.34% | 41.94% | 41.43% | -4.54% |
|
|
|||||
| Total Accounts Payable | -15.35% | 30.45% | 73.83% | 5.07% | 63.21% |
| Total Accrued Expenses | 2.96% | 0.56% | 5.74% | -13.54% | 23.13% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 106.65% | 257.47% | 226.99% | 154.05% | 60.92% |
| Total Finance Division Other Current Liabilities | -64.07% | -26.77% | -20.89% | -29.10% | 8.00% |
| Total Other Current Liabilities | -64.07% | -26.77% | -20.89% | -29.10% | 8.00% |
| Total Current Liabilities | -20.92% | 5.33% | 13.81% | -9.36% | 20.11% |
|
|
|||||
| Total Current Liabilities | -20.92% | 5.33% | 13.81% | -9.36% | 20.11% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.70% | -2.42% | 6.32% | 18.91% | 484.89% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -84.56% | -5.27% | -40.64% |
| Total Liabilities | -21.22% | -9.52% | -3.70% | 3.39% | 60.01% |
|
|
|||||
| Common Stock & APIC | 71.84% | 72.23% | 44.96% | 45.24% | 5.39% |
| Retained Earnings | -42.18% | -32.43% | -34.06% | -36.40% | -38.29% |
| Treasury Stock & Other | -169.02% | 178.82% | 42.26% | 41.51% | 88.85% |
| Total Common Equity | 111.56% | 125.75% | 57.30% | 53.94% | -19.42% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 111.56% | 125.75% | 57.30% | 53.94% | -19.42% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 111.56% | 125.75% | 57.30% | 53.94% | -19.42% |
|
|
|||||